Genmab — Marts 2021

[JørgenVarnæs]

27 days and counting down

[Helge_LarsenPI-redaktør]

Aktier/åbning: C25 fortsætter de grønne takter med Bavarian/Novo og Genmab https://www.proinvestor.com/investornyt/673102/aktier-abning-c25-fortsaetter-de-gronne-takter-med-bavarian-i-front

[nohope]

43 % on the 10 th. of february. GEN 10 th. of february 2489. 43 %added is 3.559 Ready ?

[Solsen]

Vi er på vej nohope

[Sukkeralf]

2100

[Helge_LarsenPI-redaktør]

[nohope]

Only 1.459 to go...

[exitnu]

"2100" - så er vi forud for fremtiden.

[Rondo]

Er det ikke nogen mærkelig ryk den giver både op og ned....?

[Raun]

Jo.... Tidligere på dagen, da den også var over 2100. - Der røg den tilbage i 2080 med et brag.... Hvilket faktisk godt kan se ud til at ske igen...

[Legolas23]

Tynd handel gør den let at rykke.

[E_L]

2020 was a big year for Genmab as we moved closer to achieving our vision of transforming cancer treatment and a strong pipeline of differentiated antibodies by 2025. Watch a few of our highlights... https://twitter.com/Genmab/status/1371476343079206912

[Raun]

Mange tak for denne E L

[deleted-user]

Den bliver holdt i kort snor....

[Bulder]

BofA har åbenbart haft møde med Winkel - iflg Ritzau

[E_L]

maybe at one of the 3 conferences last week, Carnegie , HC Wainwright , Barclays all hosted Genmab?

[Helge_LarsenPI-redaktør]

God morgen.

[bibob]

God morgen.

[bibob]

OncLive. https://www.onclive.com/view/dr-martin-on-the-utility-of-aggressive-frontline-treatment-in-multiple-myeloma

[bibob]

OncLive. Dr.Kumar. https://www.onclive.com/view/dr-kumar-on-the-challenges-of-selecting-therapy-in-heavily-pretreated-multiple-myeloma